Michael G. DeGroote Institute for Infectious Disease Research, McMaster Immunology Research Centre, Department of Biochemistry & Biomedical Sciences, McMaster University, Hamilton, ON, Canada.
Department of Molecular and Developmental Medicine, University of Siena, Siena, Italy.
Hum Vaccin Immunother. 2024 Dec 31;20(1):2421096. doi: 10.1080/21645515.2024.2421096. Epub 2024 Nov 17.
Although influenza A viruses predominate globally, influenza B viruses are responsible for a significant and often underappreciated burden. Despite this, immunity to influenza B viruses remains understudied, and there is a perception that vaccine-mediated immune responses to influenza B strains are less robust than influenza A strains. This targeted literature review examines this concept using data from pivotal phase 3 immunogenicity studies on currently licensed seasonal influenza vaccines and explores several explanations for this phenomenon, including immune exposure history, assay limitations, virus-related properties inherent to B lineages, and strain mismatch. Overall, studies demonstrated vaccines induce variable and sometimes less robust immune responses to influenza B strains; however, further studies are needed to fully confirm and understand these observations. In identifying the potential causes of variable performance of current vaccines against influenza, this review aims to guide vaccine development to enhance overall vaccine performance and reduce disease burden worldwide.
虽然甲型流感病毒在全球占主导地位,但乙型流感病毒也造成了相当大且常常被低估的负担。尽管如此,乙型流感病毒的免疫仍未得到充分研究,人们普遍认为乙型流感病毒株疫苗介导的免疫反应不如甲型流感病毒株那么强大。本定向文献综述使用目前已获许可的季节性流感疫苗的关键性 3 期免疫原性研究数据来检验这一概念,并探讨了导致这种现象的几个原因,包括免疫暴露史、检测方法的局限性、B 谱系病毒的固有特性以及株型错配。总的来说,研究表明疫苗对乙型流感病毒株诱导的免疫反应存在差异,有时反应较弱;然而,需要进一步的研究来充分证实和理解这些观察结果。在确定当前疫苗对流感的不同表现的潜在原因时,本综述旨在指导疫苗开发,以提高整体疫苗性能并减轻全球疾病负担。